T1	Participants 120 133	breast cancer
T2	Participants 385 406	breast cancer subtype
T3	Participants 515 551	Patients with invasive breast cancer
T4	Participants 621 734	182 patients, of whom data were available for post-NAC MRI (n=155), US (n=123), and histopathological tumour size
